Melanoma in situ of the left lower limb, including the hip, is a localized skin cancer that arises from melanocytes. It is characterized by the uncontrolled growth of these pigment-producing cells and is often caused by UV exposure. Accurate coding with ICD-10 Code D03.72 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code D03.72 specifically denotes melanoma in situ located on the left lower limb, including the hip. This code is used when documenting cases of melanoma that have not invaded deeper tissues but require monitoring and potential intervention. It is crucial for accurate clinical documentation and billing, particularly in dermatology and oncology settings.
Melanoma in situ of the left lower limb, including the hip, is a non-invasive form of skin cancer that can progress to invasive melanoma if left untreated. It is primarily caused by ultraviolet radiation exposure and necessitates prompt medical evaluation and treatment to prevent progression.
ICD-10 Code D03.72 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
In SOAP notes, ICD-10 Code D03.72 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of melanoma in situ. This code is essential for continuity of care, supporting billing processes, and meeting EHR documentation standards.
Prompt treatment of melanoma in situ is crucial to prevent progression to invasive melanoma. Surgical excision is the primary treatment modality.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D03.72 is critical for accurate billing in hospital, ER, or oncology settings.
| CPT Code | Description |
|---|---|
| 11400 | Excision, benign lesion, face, ears, scalp, neck; excised diameter up to 2.0 cm |
| 11600 | Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter up to 1.0 cm |
| 99213 | Established patient office visit, Level 3 |
Common Questions About Using ICD-10 Code D03.72 for Melanoma in situ of left lower limb, including hip
What are the risk factors for melanoma in situ?
Risk factors for melanoma in situ include excessive sun exposure, a history of sunburns, fair skin, and a family history of skin cancer. Regular skin checks are recommended for individuals with these risk factors.
How is melanoma in situ treated?
Melanoma in situ is primarily treated through surgical excision of the lesion. Follow-up care is essential to monitor for any recurrence or new lesions.
Is melanoma in situ contagious?
No, melanoma in situ is not contagious. It is a type of skin cancer that arises from genetic mutations in skin cells, primarily due to UV exposure.
What is the prognosis for melanoma in situ?
The prognosis for melanoma in situ is generally excellent when detected early and treated appropriately. The risk of progression to invasive melanoma is significantly reduced with timely intervention.
Clinical Notes
SOAP notes
DAP notes
AI medical notes